Baird Starts Crinetics (CRNX) at Outperform

Baird analyst Brian Skorney initiates coverage on Crinetics (NASDAQ: CRNX) with a Outperform rating and a price target of $48.00.

For an analyst ratings summary and ratings history on Crinetics click here. For more ratings news on Crinetics click here.

Shares of Crinetics closed at $15.31 yesterday.

You May Also Be Interested In

• H.C. Wainwright Reiterates Neutral Rating on Crinetics (CRNX)
• RBC Capital Starts Krystal Biotech (KRYS) at Outperform
• JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'